Patents by Inventor Andrew Douglas Baxter

Andrew Douglas Baxter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Quinolones and their therapeutic use
    Patent number: 5753666
    Abstract: 1-Alkyl-substituted-quinolone-3-carboxamides have therapeutic utility via inhibition of Phosphodiesterase IV esterase and/or Tumor Necrosis Factor activity.
    Type: Grant
    Filed: August 2, 1996
    Date of Patent: May 19, 1998
    Assignee: Chiroscience Limited
    Inventors: Steven Colin Beasley, John Gary Montana, Hazel Joan Dyke, Alan Findlay Haughan, George Martin Buckley, Andrew Douglas Baxter
  • Heterocyclic amides and methods of use
    Patent number: 5698706
    Abstract: Peptidyl derivatives having a SH or acylS group and which are amides, primary amides or thioamides, have therapeutic utility via MMP or TNF inhibition.
    Type: Grant
    Filed: May 10, 1996
    Date of Patent: December 16, 1997
    Assignee: Chiroscience Limited
    Inventors: Andrew Douglas Baxter, John Montana, David Alan Owen